The (nursery) rhyme and reason behind blinking | Optometry Times - Clinical News

Published on October 27, 2025
Ensuring proper hydration of the eye takes more moonlight and lullabies.
Continue reading on website
Other news

Drugs Recognized as Potential Maculopathy Risk Factors

October 27, 2025
The FDA Adverse Event Reporting System was used to find five drug candidates with the highest underrecognized maculopathy risk—fingolimod, apixaban, paclitaxel, ibrutinib and sildenafil. However, cumulative incidence rates were high among four of these candidates—apixaban, paclitaxel, ibrutinib and sildenafil—meaning they should be evaluated further for maculopathy both in practice and in clinical

Application for Branded Atropine Drug Rejected by FDA

October 27, 2025
Sydnexis said in a statement that it remains confident in its data and will work with the FDA to address concerns that might allow for an eventual approval of SYD-101. Photo: Getty Images. Click image to enlarge. Prescribing topical atropine is a popular intervention to reduce myopic progression, but it will have to remain an off-label practice in the United States for now.